{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:30:15Z","timestamp":1776922215777,"version":"3.51.2"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.nbd.2015.11.019","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T12:20:12Z","timestamp":1448454012000},"page":"41-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery"],"prefix":"10.1016","volume":"86","author":[{"given":"Ilaria","family":"Ceccarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-6648","authenticated-orcid":false,"given":"Pasquale","family":"Fiengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Remelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-5695","authenticated-orcid":false,"given":"Vincenzo","family":"Miragliotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Biotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Petricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Caricasole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pollio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Scali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.11.019_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(91)91403-N","article-title":"Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons","volume":"568","author":"Anderson","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.11.019_bb0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","article-title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum","volume":"28","author":"Arlotta","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.11.019_bb0020","series-title":"Huntington Disease. Nature Reviews Disease Primers","author":"Bates","year":"2015"},{"key":"10.1016\/j.nbd.2015.11.019_bb0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0030","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.11.019_bb0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2015.11.019_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.870110605","article-title":"Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons","volume":"11","author":"Cicchetti","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.11.019_bb0045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2015.11.019_bb0050","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-11-81","article-title":"An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector","volume":"11","author":"de Backer","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0060","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0065","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.11.019_bb0070","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.11.019_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.drudis.2009.02.006","article-title":"Small molecule drug discovery for Huntington's disease","volume":"14","author":"Fecke","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nbd.2015.11.019_bb0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington's disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2015.11.019_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.11.019_bb0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2015.11.019_bb0095","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-386509-0.00012-0","article-title":"Adeno-associated virus vectorology, manufacturing, and clinical applications","volume":"507","author":"Grieger","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.nbd.2015.11.019_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/WCO.0b013e3283550c97","article-title":"Huntington's disease","volume":"25","author":"Ha","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2015.11.019_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jgm.1150","article-title":"Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion","volume":"10","author":"Huang","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.nbd.2015.11.019_bb0115","doi-asserted-by":"crossref","first-page":"14032","DOI":"10.1038\/mtm.2014.32","article-title":"Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model","volume":"1","author":"Huda","year":"2014","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.nbd.2015.11.019_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2015.11.019_bb0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/ml400251g","article-title":"Fused 3-hydroxy-3-trifluoromethylpyrazoles inhibit mutant huntingtin toxicity","volume":"4","author":"La Rosa","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2015.11.019_bb0135","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1111\/febs.12418","article-title":"Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis","volume":"280","author":"Lee","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2015.11.019_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington's disease","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.11.019_bb0145","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1523\/JNEUROSCI.19-13-05159.1999","article-title":"Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin","volume":"19","author":"Li","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0150","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/hmg\/9.19.2859","article-title":"Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis","volume":"9","author":"Li","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0155","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.11.019_bb0165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1471-4159.2009.06010.x","article-title":"Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system","volume":"109","author":"McFarland","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.11.019_bb0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2015.11.019_bb0175","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington's disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.11.019_bb0180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"M\u00f6ller","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2015.11.019_bb0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntington's disease","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.11.019_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.nbd.2015.11.019_bb0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"1979","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"10.1016\/j.nbd.2015.11.019_bb0200","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2015.11.019_bb0205","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.11.019_bb0210","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.nbd.2015.11.019_bb0215","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2015.11.019_bb0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"Politis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.11.019_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051069","article-title":"Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism","volume":"7","author":"Popiel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.11.019_bb0230","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"key":"10.1016\/j.nbd.2015.11.019_bb0235","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","article-title":"Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum","volume":"12","author":"R\u00e9gulier","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.11.019_bb0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2011.08.023","article-title":"Viral-mediated overexpression of mutant huntingtin to model HD in various species","volume":"48","author":"Ruiz","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.11.019_bb0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain","volume":"20","author":"Senut","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0260","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0265","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"75","key":"10.1016\/j.nbd.2015.11.019_bb0270","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"9","author":"Sturrock","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.11.019_bb0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington's disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2015.11.019_bb0280","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.11.019_bb0285","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.11.019_bb0290","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","article-title":"MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition","volume":"33","author":"Taylor","year":"2013","journal-title":"J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2015.11.019_bb0295","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1002\/jgm.506","article-title":"Recombinant AAV-mediated gene delivery to the central nervous system","volume":"6","author":"Tenenbaum","year":"2004","journal-title":"J. Gene. Med."},{"key":"10.1016\/j.nbd.2015.11.019_bb0300","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.11.019_bb0305","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1471-4159.2005.02986.x","article-title":"Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates","volume":"92","author":"Tsuji","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.11.019_bb0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington's disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.11.019_bb0320","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.11.019_bb0325","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.11.019_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mrm.22579","article-title":"A constrained least-squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data","volume":"65","author":"Wilson","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.nbd.2015.11.019_bb0335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.11.019_bb0340","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.11.019_bb0345","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.11.019_bb0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.wad.0000213809.12553.fc","article-title":"Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging","volume":"20","author":"Zhu","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"293","key":"10.1016\/j.nbd.2015.11.019_bb0355","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"20","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:51:54Z","timestamp":1567363914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115300978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":71,"alternative-id":["S0969996115300978"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.11.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}